HIMSHims & Hers Health, Inc.

NYSE forhims.com


$ 23.16 $ 1.01 (4.56 %)    

Tuesday, 25-Jun-2024 15:59:56 EDT
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 23.16
$ 22.22
$ 0.00 x 0
$ 0.00 x 0
$ 22.17 - $ 23.41
$ 5.65 - $ 25.74
7,626,902
na
5.31B
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-22-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-29-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avidity-biosciences-and-cleanspark-were-among-the-10-biggest-mid-cap-stock-gainers-last-week-june-9-june-15-are-these-in-your-portfolio

Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, Cle...

 b-of-a-securities-maintains-buy-on-hims--hers-health-raises-price-target-to-26

B of A Securities analyst Michael Cherny maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target...

Core News & Articles

https://www.statnews.com/2024/06/11/google-verily-glp1-weight-loss-drugs-lightpath-onduo/

Core News & Articles

NVDAAAPLAIWAYTSLALOTAMDHIMSCORNGMEData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

Core News & Articles

- Reuters

 b-of-a-securities-maintains-buy-on-hims--hers-health-raises-price-target-to-22

B of A Securities analyst Michael Cherny maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target...

 canaccord-genuity-maintains-buy-on-hims--hers-health-raises-price-target-to-24

Canaccord Genuity analyst Maria Ripps maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target fr...

 citigroup-downgrades-hims--hers-health-to-neutral-raises-price-target-to-20

Citigroup analyst Daniel Grosslight downgrades Hims & Hers Health (NYSE:HIMS) from Buy to Neutral and raises the price t...

 exclusive-roundhill-investments-launches-weight-loss-etf-for-exposure-to-blockbuster-drugs-like-ozempic

Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and c...